Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of Ionis Pharmaceuticals's Olezarsen Sodium?
Olezarsen Sodium is an antisense oligonucleotide commercialized by Ionis Pharmaceuticals, with a leading Pre-Registration program in Familial Chylomicronemia (Type I...